William Blair Remains a Buy on Verve Therapeutics (VERV)
William Blair analyst Myles Minter reiterated a Buy rating on Verve Therapeutics (VERV – Research Report) today. The company’s shares opened ...
Seeking Alpha3d
Verve Therapeutics: HeFH Treatment Program Of VERVE-102 Remains On Track With 2025 Catalysts
Verve Therapeutics (NASDAQ:VERV) just today announced that it had received IND clearance from the FDA in the United States in order to advance its 2nd gene editing candidate VERVE-102 for the ...
Bloomberg L.P.2d
Latest Sector News
US President Donald Trump signed a proclamation to implement a 25% tariff on auto imports. The proclamation specified automobile tariffs would be collected starting at 12:01 a.m. Washington time ...
BioPharma Dive5d
Verve gets FDA green light to expand base editing trial into US
Verve Therapeutics is expanding a gene editing trial for a cholesterol and heart disease treatment into the U.S., the company said Monday after receiving clearance from the Food and Drug ...
MarketWatch2d
S&P 500 Industrial Gases Sub Industry Index
IPC Indice de Precios Y Cotizaciones 52,806.89-396.37-0.75% ...
uDiscover3d
Pretty Hate Machines: A Beginner’s Guide To Industrial Music
Cacophonic loops. Dyspeptic lyrics. Abrasive vocals. These are the calling cards of industrial music, the anti-establishment genre that made its mark by bridging art-rock with aggression ...